TOVX – theriva biologics, inc. (US:AMEX)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

TOVX

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/29

08:00 am

tovx

Theriva™ Biologics Announces Positive Scientific Advice from the European Medicines Agency (EMA) on the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Low Report

Theriva™ Biologics Announces Positive Scientific Advice from the European Medicines Agency (EMA) on the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Report

11/12

08:48 am

tovx

Theriva™ Biologics Reports Third Quarter 2025 Operational Highlights and Financial Results [Yahoo! Finance]

Low Report

Theriva™ Biologics Reports Third Quarter 2025 Operational Highlights and Financial Results [Yahoo! Finance]

Report

11/12

08:00 am

tovx

Theriva™ Biologics Reports Third Quarter 2025 Operational Highlights and Financial Results

Medium Report

Theriva™ Biologics Reports Third Quarter 2025 Operational Highlights and Financial Results

Report

10/24

02:31 pm

tovx

Theriva Biologics Provides Response to Unusual Market Action

High Report

Theriva Biologics Provides Response to Unusual Market Action

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.